Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00650130
Other study ID # KTL 417-7
Secondary ID
Status Completed
Phase N/A
First received March 27, 2008
Last updated November 1, 2013
Start date May 2008
Est. completion date October 2011

Study information

Verified date November 2013
Source National Institute for Health and Welfare, Finland
Contact n/a
Is FDA regulated No
Health authority Finland: Ministry of Social Affairs and HealthFinland: Ethics Committee
Study type Observational

Clinical Trial Summary

The aim of this study is to get new information on the whole blood-plasma-oral fluid ratios of psychoactive drugs which are encountered in traffic.

Samples are taken from drivers suspected of being under the influence of drugs or medicines. The samples are analysed with immunological methods and GC-MS.

Observations from Police and a physician on impairment are combined with the results of the different bodily fluids. Observational evaluations and substance concentrations are compared.


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date October 2011
Est. primary completion date December 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years or older

- driver of a motorised vehicle

Exclusion Criteria:

- 17 years or younger

- not the driver of a motorised vehicle

Study Design

Observational Model: Case Control


Related Conditions & MeSH terms


Locations

Country Name City State
Finland National Public Health Institute Helsinki

Sponsors (4)

Lead Sponsor Collaborator
National Institute for Health and Welfare, Finland European Commission, Helsinki University, Ministry of Internal Affairs, Finland

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary ratio of psychoactive drugs/medicines in whole blood-plasma-saliva and correlation to symptoms of impairment 1 year Yes
Secondary prevalence of psychoactive substances in the general driving population three years Yes
See also
  Status Clinical Trial Phase
Completed NCT00648206 - Testing Alcohol Only Samples for Drugs and Drugs Only Samples for Alcohol N/A
Completed NCT04230460 - Cannabis Impairment Detection Application (CIDA) N/A
Completed NCT03506880 - Project MADD - NIH Underage DUI and Ride N/A
Completed NCT05028413 - Evaluating Perceived Fitness to Drive While Intoxicated N/A
Completed NCT02071836 - A Web Application to Reduce Heavy Drinking in First-time DWI Offenders N/A
Recruiting NCT04450966 - Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care N/A
Completed NCT04247191 - Parent Intervention to Reduce College Student Drinking and Consequences N/A
Completed NCT04970342 - Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim Phase 1
Completed NCT03335735 - Smartphone-paired Breathalyzers and Loss- and Gain-framed Texts for Reducing Drinking and Driving N/A
Active, not recruiting NCT01590277 - Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans Phase 1
Withdrawn NCT05273658 - Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests Phase 1/Phase 2
Completed NCT05437081 - A Family-Based Alcohol Preventive Intervention for Latino Emerging Adults N/A
Not yet recruiting NCT05526196 - Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes N/A
Completed NCT03503396 - Alcohol Impaired Driving in the Natural Environment N/A